-+ 0.00%
-+ 0.00%
-+ 0.00%
Castle Biosciences CEO Derek Maetzold disposes of $202,507 in common shares
Share
Listen to the news
Castle Biosciences CEO Derek Maetzold disposes of $202,507 in common shares
  • Castle Biosciences CEO Derek J. Maetzold sold 6,214 shares on July 27, 2026, cutting his direct stake to 21,479 shares.
  • Sales were priced at USD 24.13 and USD 25.06, totaling 7,521 shares across direct holdings and family trusts.
  • He also exercised stock options for 6,214 shares at USD 2.39.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-050616), on July 29, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending